Affiliation:
1. Institute of Cellular and Molecular Biology, School of Life Science, Jiangsu Normal University, Xuzhou 221116, China
Abstract
Adipocytes are crucial for maintaining energy balance. Adipocyte differentiation involves distinct stages, including the orientation stage, clone amplification stage, clone amplification termination stage, and terminal differentiation stage. Understanding the regulatory mechanisms governing adipogenic differentiation is essential for comprehending the physiological processes and identifying potential biomarkers and therapeutic targets for metabolic diseases, ultimately improving glucose and fat metabolism. Adipogenic differentiation is influenced not only by key factors such as hormones, the peroxisome proliferator-activated receptor (PPAR) family, and the CCATT enhancer-binding protein (C/EBP) family but also by noncoding RNA, including microRNA (miRNA), long noncoding RNA (lncRNA), and circular RNA (circRNA). Among these, lncRNA has been identified as a significant regulator in adipogenic differentiation. Research has demonstrated various ways in which lncRNAs contribute to the molecular mechanisms of adipogenic differentiation. Throughout the adipogenesis process, lncRNAs modulate adipocyte differentiation and development by influencing relevant signaling pathways and transcription factors. This review provides a brief overview of the function and mechanism of lncRNAs in adipogenic differentiation.
Funder
Program of Natural Science Foundation of Jiangsu Normal University
National Natural Science Foundation of China
Priority Academic Program Development of Jiangsu Higher Education
Reference126 articles.
1. Adipocyte and adipogenesis;Ali;Eur. J. Cell Biol.,2013
2. Adipose tissue—Morphological and biochemical characteristic of different depots;Postep. Hig. Med. Dosw.,2017
3. Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A.J., Gojobori, T., and Isenovic, E.R. (2021). Leptin and Obesity: Role and Clinical Implication. Front. Endocrinol., 12.
4. Achari, A.E., and Jain, S.K. (2017). Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Int. J. Mol. Sci., 18.
5. Resistin’s, obesity and insulin resistance: The continuing disconnect between rodents and humans;Huang;J. Endocrinol. Investig.,2016